Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Feb 15, 2024; 16(2): 475-492
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.475
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.475
Figure 5 Correlation analysis of B56ε expression with immune checkpoint genes, human leukocyte antigen-associated genes and drug sensitivity.
A: Correlation analysis between immune checkpoint genes and the expression of B56ε; B: Correlation analysis between human leukocyte antigen-associated genes and the expression of B56ε; C and D: Association between anticancer drug response and B56ε expression in the CellMiner database. aP < 0.05; bP < 0.01; cP < 0.001. HLA: Human leukocyte antigen; NS: Not significant.
- Citation: Wu HM, Huang YY, Xu YQ, Xiang WL, Yang C, Liu RY, Li D, Guo XF, Zhang ZB, Bei CH, Tan SK, Zhu XN. Comprehensive analysis of the protein phosphatase 2A regulatory subunit B56ε in pan-cancer and its role and mechanism in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(2): 475-492
- URL: https://www.wjgnet.com/1948-5204/full/v16/i2/475.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i2.475